RSS-Feed abonnieren

DOI: 10.1055/a-2689-3271
Revisional endoscopic sleeve gastroplasty for failed laparoscopic sleeve gastrectomy in an immunocompromised patient
Authors

We present a case of a 48-year-old woman with a pertinent past medical history of laparoscopic sleeve gastrectomy (roughly seven and a half years prior) for treatment of class three obesity, rheumatoid arthritis on infliximab, and pyrosis-predominant gastroesophageal reflux disease who presented for endoscopic management of weight recidivism despite surgical bariatric therapy. Of the initial 33.3 kg lost, she had regained 30.8 kg. Staging esophagogastroduodenoscopy (EGD) revealed postsurgical sleeve dilation of the gastric body ([Fig. 1]). She underwent revisional endoscopic sleeve gastroplasty (r-ESG), which incorporated a “U → I → U → I” suture pattern ([Fig. 2], [Fig. 3], [Fig. 4]). Seven months post r-ESG, surveillance EGD demonstrated persistent narrowing of the gastric body and some widening at the distal end ([Fig. 5]) with the patient down 10.8 kg.










Laparoscopic sleeve gastrectomy (LSG) serves as a common modality for the management of obesity; however, its long-term (≥7 years) efficacy is questionable given the incidence of weight regain/recidivism (<50% excess weight loss) is approximately 27.8% with a range of 14%–37% [1]. While no consensus regarding optimal revisional management of LSG exists, revisional surgical bariatric therapy has shown increased risk – varying from 5% to 20% – for adverse events and higher overall morbidity relative to initial surgical bariatric therapy [2]. Despite limited sample size(s), several studies have indicated that r-ESG provides sustained weight loss at the one- and two-year intervals for post-LSG weight regain [2] [3]. As minimal literature exists regarding this topic, little is known about its effectiveness in atypical cases. Thus, this case depicts successful management of refractory obesity due to post-LSG weight recidivism in an immunocompromised patient via r-ESG ([Video 1]).
Treatment of post-laparoscopic sleeve gastrectomy weight recidivism via revisional endoscopic sleeve gastroplasty in an immunocompromised patient.Video 1Endoscopy_UCTN_Code_TTT_1AO_2AN
E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy.
All papers include a high-quality video and are published with a Creative Commons
CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission
process. We grant 100% waivers to articles whose corresponding authors are based in
Group A countries and 50% waivers to those who are based in Group B countries as classified
by Research4Life (see: https://www.research4life.org/access/eligibility/).
This section has its own submission website at https://mc.manuscriptcentral.com/e-videos.
Publikationsverlauf
Artikel online veröffentlicht:
09. September 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Clapp B, Wynn M, Martyn C. et al. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis 2018; 14: 741-747
- 2 Maselli DB, Alqahtani AR, Abu Dayyeh BK. et al. Revisional endoscopic sleeve gastroplasty of laparoscopic sleeve gastrectomy: an international, multicenter study. Gastrointest Endosc 2021; 93: 122-130
- 3 Deng J, Wool J, Montecino RB. et al. Efficacy of revisional endoscopic sleeve gastroplasty after laparoscopic sleeve gastrectomy. Obes Surg 2025; 35: 582-586